Beijing Geekgene Technology Co., Ltd

This early-stage trial tests a new cell therapy called GK01 in 15 people with advanced solid tumors that have stopped responding to standard treatments. The therapy uses the patient's own immune cells, which are trained in a lab to attack cancer cells. The main goals are to find …

This early-stage trial tests a personalized cell therapy called GK01 for people with advanced solid tumors who have no standard treatment options left. The therapy uses a patient's own immune cells, trained to attack their tumor. The main goal is to check safety, with a secondary…